SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-24-002584
Filing Date
2024-04-17
Accepted
2024-04-16 19:22:29
Documents
14
Period of Report
2024-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgen_8k.htm   iXBRL 8-K 28900
2 EXHIBIT 10.1 opgen_ex10-1.htm EX-10.1 61852
  Complete submission text file 0001829126-24-002584.txt   283204

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE opgn-20240411.xsd EX-101.SCH 2991
4 XBRL LABEL FILE opgn-20240411_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE opgn-20240411_pre.xml EX-101.PRE 22343
17 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3645
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 24849056
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)